Luca Arcari,Giovanni Camastra,Federica Ciolina et al.
Luca Arcari et al.
Uremic cardiomyopathy (UC) is the cardiac remodelling that occurs in patients with chronic kidney disease (CKD). It is characterised by a left ventricular (LV) hypertrophy phenotype, diastolic dysfunction and generally preserved LV ejection...
Aliza Hussain,Arunima Misra,Biykem Bozkurt
Aliza Hussain
Heart failure (HF) is a major health problem worldwide. The development of effective drug and/or device therapy is crucial to mitigate the significant morbidity, mortality and healthcare costs associated with HF. The choice of endpoint in c...
Abhishek Dattani,Rachana Prasad
Abhishek Dattani
Sigrid L Johannesen,Colin M Barker,Melissa M Levack
Sigrid L Johannesen
Ischaemic mitral regurgitation is a complex process with debate in the literature as to the optimal treatment pathway. Multiple therapies are available to alleviate mitral regurgitation including medical management, transcatheter edge-to-ed...
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure [0.03%]
心力衰竭患者中CA125介导的充血与炎症之间的关系
Marko Kumric,Tina Ticinovic Kurir,Josko Bozic et al.
Marko Kumric et al.
Because heart failure (HF) is more lethal than some of the common malignancies in the general population, such as prostate cancer in men and breast cancer in women, there is a need for a cost-effective prognostic biomarker in HF beyond natr...
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction [0.03%]
填补空白的理由：快速启动并优化射血分数降低的心力衰竭的综合疾病修正药物治疗方案
Nicholas K Brownell,Boback Ziaeian,Gregg C Fonarow
Nicholas K Brownell
There are gaps in the use of therapies that save lives and improve quality of life for patients with heart failure with reduced ejection fraction, both in the US and abroad. The evidence is clear that initiation and titration of guideline-d...
Gerard T Giblin,Laura Murphy,Garrick C Stewart et al.
Gerard T Giblin et al.
Sarcoidosis is a complex, multisystem inflammatory disease with a heterogeneous clinical spectrum. Approximately 25% of patients with systemic sarcoidosis will have cardiac involvement that portends a poorer outcome. The diagnosis, particul...
Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors [0.03%]
心房颤动引起左室收缩功能障碍的临床及超声心动图预测指标分析
Erez Marcusohn,Ofer Kobo,Maria Postnikov et al.
Erez Marcusohn et al.
Background: Diagnosis of AF-induced cardiomyopathy can be challenging and relies on ruling out other causes of cardiomyopathy and, after restoration of sinus rhythm, recovery of left ventricular (LV) function. The aim of this study was to i...
Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy [0.03%]
他汀类药物强度对心脏移植血管病进展的影响
Tracey M Ellimuttil,Kimberly Harrison,Allman T Rollins et al.
Tracey M Ellimuttil et al.
Background: In the non-transplant population, hyperlipidaemia has shifted from targeting LDL goals to statin intensity-based treatment. It is unknown whether this strategy is also beneficial in cardiac transplantation. Methods: This single-...
Unknown Risks of Transplantation in Adults with Congenital Heart Disease [0.03%]
成人先天性心脏病移植的风险未知因素分析
Aniket S Rali,Angela Weingarten,Emily Sandhaus et al.
Aniket S Rali et al.